Cleared Special

Spectra Optia Apheresis System

K153601 · Terumobct, Inc. · Gastroenterology & Urology
Jan 2016
Decision
29d
Days
Risk

About This 510(k) Submission

K153601 is an FDA 510(k) clearance for the Spectra Optia Apheresis System, a Separator, Automated, Blood Cell And Plasma, Therapeutic, submitted by Terumobct, Inc. (Lakewood, US). The FDA issued a Cleared decision on January 14, 2016, 29 days after receiving the submission on December 16, 2015. This device falls under the Gastroenterology & Urology review panel.

Submission Details

510(k) Number K153601 FDA.gov
FDA Decision Cleared SESE
Date Received December 16, 2015
Decision Date January 14, 2016
Days to Decision 29 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code LKN — Separator, Automated, Blood Cell And Plasma, Therapeutic
Device Class

Similar Devices — LKN Separator, Automated, Blood Cell And Plasma, Therapeutic

All 26
AMICUS Separator System
K192150 · Fresenius Kabi AG · Nov 2019
Spectra Optia Apheresis System
K183081 · Terumobct, Inc. · Feb 2019
AMICUS Separator System, AMICUS Exchange Kit - Therapeutics, Waste Transfer Set, Blood Component Filter Set With Vented Spike and Luer Adapter
K180615 · Fresenius Kabi USA,Llc · Dec 2018
Spectra Optia Apheresis System
K181049 · Terumobct, Inc. · Nov 2018
Spectra Optia Apheresis System
K172590 · Terumobct, Inc. · Mar 2018
Spectra Optia Apheresis System, Spectra Optia Exchange Set (with AC Connection), Spectra Optia AC Connection Adapter
K151368 · Terumo Bct · Sep 2015